资讯

Small Caps29 分钟
INOVIQ reports 88% kill rate of breast and lung cancer cells in CAR-exosome therapy study
INOVIQ (ASX: IIQ) has reported superior efficacy from an in vitro study of CAR-exosomes cancer therapy that killed almost 88% ...